Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

Postnatal Hydrocortisone for Preventing or Treating Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review

(2010) Lex W. Doyle et al.   Neonatology

Open-Label Glucocorticoids Modulate Dexamethasone Trial Results in Preterm Infants

(2010) W. Onland et al.   PEDIATRICS

A preliminary study into the economic burden of cerebral palsy in China

(2008) Bin Wang et al.   HEALTH POLICY

Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Disease: A Meta-analysis

(2008) W. Onland et al.   PEDIATRICS

Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials

(2008) W. Onland et al.   PEDIATRICS

Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up

(2007) K J Rademaker et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition